Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
ProMIS Neurosciences
531
ProMIS Neurosciences
Technology
Biotechnology
We are a development stage biotech company harnessing the power of precision medicine to conquer Alzheimer’s disease and ALS.
Suggest edits
Type
B2b
Raised
$722.5k
Follow us
Also headquartered in Toronto
Robin
Ashley Madison
Wattpad
MaRS
Wealthsimple
LEAGUE
BMO
CPPIB
1Password
Polar
Companies in the same industry
Neogene Therapeutics
Carmot Therapeutics, Inc.
Leto Lab
Visen Pharmaceuticals
23andMe
Vanda Pharmaceuticals
ScripsAmerica
Celgene Corporation
Interface Biologics
Entopsis
Alexa global traffic share
Twitter followers
Overview
Funding
2
Add info
Latest funding
$262,500
Grant - 2017
Canadian Institutes of Health Research
$460,000
Venture capital (Series UNDISCLOSED) - 2016
Team Size
1–10
Employees
I work here
Location
Toronto
,
Canada
Headquarters
Explore Toronto
neurons.AI
ProMIS Neurosciences announces adjournment and change of location of annual meeting of …
neurons.AI
ProMIS Neurosciences and collaborator BC Neuroimmunology announce significant progress on …
neurons.AI
ProMIS Neurosciences, Inc.
neurons.AI
ProMIS Neurosciences and collaborative team receive Supercluster Award supporting avoidance …
neurons.AI
ProMIS Neurosciences Chairman’s Update details new programs from expanded use of novel …
the home of AI info
ProMIS Neurosciences, Inc
the home of AI info
ProMIS Neurosciences Announces First Quarter 2020 Results
the home of AI info
ProMIS Neurosciences Announces First Quarter 2020 Results
the home of AI info
BRIEF-ProMIS Neurosciences Reports Q1 Net Loss Of $1.8 Million
the home of AI info
ProMIS Neurosciences identifies multiple novel targets on SARS CoV-2 for development of a …
the home of AI info
ProMIS Neurosciences develops novel antagonists for RACK1, a protein involved in numerous …
the home of AI info
ProMIS Neurosciences develops novel antagonists for RACK1, a protein involved in numerous …
the home of AI info
ProMIS Neurosciences creates novel intrabodies for ALS, frontotemporal dementia and other …
the home of AI info
ProMIS Neurosciences creates novel intrabodies for ALS, frontotemporal dementia and other …
the home of AI info
Worth Watching Stock: ProMIS Neurosciences (OTC:ARFXF)
the home of AI info
Worth Watching Stock: ProMIS Neurosciences (TSX:PMN)
the home of AI info
ProMIS Neurosciences commends Biogen for clarifying aducanumab regulatory filing
the home of AI info
ProMIS Neurosciences : Journal of the American Academy of Neurology Publishes ProMIS …
the home of AI info
Journal of the American Academy of Neurology Publishes ProMIS Neurosciences‘ Abstracts on …
the home of AI info
Journal of the American Academy of Neurology Publishes ProMIS Neurosciences‘ Abstracts on …
